1
|
Serrao A, Loglisci G, Salaroli A, Zacheo I, Alimena G, Breccia M. Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization. Leuk Lymphoma 2012; 54:411-2. [PMID: 22694794 DOI: 10.3109/10428194.2012.702905] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
MESH Headings
- Antimetabolites, Antineoplastic/administration & dosage
- Antimetabolites, Antineoplastic/therapeutic use
- Azacitidine/administration & dosage
- Azacitidine/therapeutic use
- Combined Modality Therapy
- Humans
- Leukemia, Myelomonocytic, Chronic/drug therapy
- Leukemia, Myelomonocytic, Chronic/radiotherapy
- Leukemia, Myelomonocytic, Chronic/therapy
- Male
- Middle Aged
- Sarcoma, Myeloid/drug therapy
- Sarcoma, Myeloid/radiotherapy
- Treatment Outcome
Collapse
|
2
|
Yagi T, Ishikawa J, Takahashi M, Yamashita Y, Kusakabe S, Yoshinami T, Masaie H, Sugimoto N, Yoshida H, Imamura F. Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapy. Intern Med 2012; 51:769-72. [PMID: 22466836 DOI: 10.2169/internalmedicine.51.6652] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Myeloid sarcoma (MS) is a tumor consisting of myeloid blasts that occurs at an anatomical site other than the bone marrow. We report the case of a 38-year-old man with duodenal MS who underwent an allogeneic bone marrow transplant in a non-complete remission (CR) state. After the transplant, residual disease was suspected on a fluorodeoxyglucose positron emission tomography (FDG-PET)/CT scan, and additional radiotherapy resulted in CR, which has been maintained for 21 months. FDG-PET/CT scanning is useful for evaluating residual myeloid sarcoma during the peritransplant period.
Collapse
Affiliation(s)
- Toshinari Yagi
- Department of Clinical Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Rodríguez Pérez A, López Carrizosa MC, Villalón Blanco L, Samper Ots PM, Ortiz Cruz E. Granulocytic sarcoma of the right humerus in a non-leukaemia patient. Clin Transl Oncol 2008; 10:758-60. [PMID: 19015073 DOI: 10.1007/s12094-008-0283-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Granulocytic sarcoma (GS), an uncommon solid extramedullary tumour, should be considered even in the absence of leukaemia, as delay in diagnosis and treatment worsens the prognosis. We present a GS (single humeral bone lesion) in a non-leukaemia patient, treated with intensive AML (Acute Myeloid Leukaemia) chemotherapy and sequential radiotherapy, in complete response 26 months after diagnosis, confirmed by histopathology and without leukaemia progression.
Collapse
Affiliation(s)
- Aurora Rodríguez Pérez
- Radiation Oncology Department, Hospital Central de la Defensa Gómez-Ulla, Madrid, Spain.
| | | | | | | | | |
Collapse
|
4
|
Tsuboi K, Kawada H, Suzuki R, Murayama H, Ohmachi K, Nakamura N, Ogawa Y, Ando K. [Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia]. Rinsho Ketsueki 2008; 49:1562-1565. [PMID: 19047789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
A 71-year-old man presented with progressive dysuria. Several imaging examinations indicated possibility of prostate tumor, therefore he underwent prostate biopsy. This resulted in a diagnosis of granulocytic sarcoma of the prostate. Since bone marrow appeared normal on aspiration biopsy, he was treated with local irradiation. Prostate swelling then markedly diminished and his symptoms disappeared. However, four months later he progressed to AML. He then received systemic chemotherapy and achieved complete remission. We discuss the management of granulocytic sarcoma when findings do not indicate overt leukemia at the time of diagnosis.
Collapse
Affiliation(s)
- Kosuke Tsuboi
- Division of Hematology/Oncology, Department of Medicine, Tokai University School of Medicine
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Altintas A, Cil T, Kilinc I, Kaplan MA, Ayyildiz O. Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report. J Neurooncol 2007; 84:103-5. [PMID: 17318411 DOI: 10.1007/s11060-007-9352-0] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2006] [Accepted: 02/01/2007] [Indexed: 10/23/2022]
Abstract
Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by a reciprocal translocation between chromosomes 9 and 22. Imatinib mesylate is a potent and selective inhibitory of the BCR/ABL tyrosine kinase. Imatinib is a first choice of treatment of chronic phase CML. It has also shown activity in patients with CML in accelerated or blastic phases. However, the penetration of the drug and its active metabolites into the central nervous system (CNS) is poor. Therefore, the CNS is sanctuary site for malignant cells in patients treated with imatinib. Herein, we report a patient with CML in accelerated phase that developed central nervous system disease while on imatinib mesylate therapy.
Collapse
Affiliation(s)
- Abdullah Altintas
- Internal Medicine, Department of Hematology-Oncology, Dicle University, 21280, Diyarbakir, Turkey.
| | | | | | | | | |
Collapse
|
6
|
Chouchary DR, Bhattacharya M, Mishtra P, Mahapatra M, Kumar R. Granulocytic sarcoma of spine: an unusual initial presentation of acute myeloid leukemia. J Assoc Physicians India 2006; 54:897. [PMID: 17249265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
|
7
|
Savranlar A, Ustündag Y, Ozer T, Bayraktaroglu T, Demircan N, Ozdemir H, Borazan A. A thoracic-epidural granulocytic sarcoma case that was diagnosed preceding the onset of and that recurred co-incidental to acute promyelocytic leukemia, which developed after surgical treatment. Acta Med Okayama 2005; 58:251-4. [PMID: 15666994 DOI: 10.18926/amo/32104] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Granulocytic sarcoma or chloroma is a tumor seen in myelocytic leukemia. Spinal epidural onset is rare and is generally seen before or together with the onset of myelocytic leukemia. An epidural mass located at the 2nd-5th thoracic levels in an 18-year-old male patient was pathologically diagnosed as granulocytic sarcoma. Radiotherapy was performed after surgical intervention. Ten months later, he was re-admitted with abdominal pain. At this time, an epidural mass at the 6th-9th thoracic levels was detected on magnetic resonance imaging, and acute promyelocytic leukemia was diagnosed. After systemic chemotherapy, partial remission was achieved. We aimed to present this rare case with its remarkable follow-up findings.
Collapse
MESH Headings
- Adolescent
- Antibiotics, Antineoplastic/administration & dosage
- Antimetabolites, Antineoplastic/administration & dosage
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Combined Modality Therapy
- Cytarabine/administration & dosage
- Daunorubicin/administration & dosage
- Epidural Space
- Humans
- Leukemia, Promyelocytic, Acute/drug therapy
- Magnetic Resonance Imaging
- Male
- Neoplasm Recurrence, Local
- Neoplasms, Second Primary
- Sarcoma, Myeloid/diagnosis
- Sarcoma, Myeloid/pathology
- Sarcoma, Myeloid/radiotherapy
- Sarcoma, Myeloid/surgery
- Spinal Neoplasms/diagnosis
- Thoracic Vertebrae
Collapse
Affiliation(s)
- Ahmet Savranlar
- Department of Radiology, Zonguldak Karaelmas University, Faculty of Medicine, Zonguldak, Turkey.
| | | | | | | | | | | | | |
Collapse
|
8
|
Dikbas O, Isik M, Purnak T, Karadag O, Uner A, Altundag K. Isolated granulocytic sarcoma of the head and neck preceding acute myeloid leukemia. Am J Hematol 2004; 76:95-6. [PMID: 15114610 DOI: 10.1002/ajh.20021] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
MESH Headings
- Adult
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Biopsy, Needle
- Diagnosis, Differential
- Humans
- Leukemia, Myeloid, Acute/diagnosis
- Leukemia, Myeloid, Acute/drug therapy
- Leukemia, Myeloid, Acute/pathology
- Magnetic Resonance Imaging
- Male
- Parotid Neoplasms/diagnosis
- Parotid Neoplasms/drug therapy
- Parotid Neoplasms/pathology
- Parotid Neoplasms/radiotherapy
- Remission Induction
- Sarcoma, Myeloid/diagnosis
- Sarcoma, Myeloid/drug therapy
- Sarcoma, Myeloid/pathology
- Sarcoma, Myeloid/radiotherapy
Collapse
|
9
|
Abstract
Granulocytic sarcoma is a rare tumor composed of neoplastic blood cells, typically occurring during the course of, or before the onset of, acute nonlymphoblastic leukemia. We present a case of a 37-year-old man with acute testicular pain who was found to have a testicular mass diagnosed as granulocytic sarcoma (GS). Because GS virtually always progresses to leukemia, he underwent postoperative radiotherapy and chemotherapy. He was free of disease 6 months after treatment. This case highlights a rare hematologic cancer that urologists and pathologists should be aware of because it can present as a testicular mass.
Collapse
Affiliation(s)
- S E Eggener
- Department of Urology, Northwestern University School of Medicine, Chicago, Illinois 60611, USA
| | | | | |
Collapse
|
10
|
Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, Thomas DA, Garcia-Manero G, Ferrajoli A, Manning JT, Keating MJ, Albitar M, O'Brien S, Giles FJ. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia 2003; 17:1100-3. [PMID: 12764375 DOI: 10.1038/sj.leu.2402958] [Citation(s) in RCA: 163] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Granulocytic sarcoma (GS) is an extramedullary tumor composed of immature myeloid cells. The objectives of this study were to describe the frequency, presenting characteristics, and survival in patients with nonleukemic GS by conducting a review of all untreated patients presenting to the MD Anderson Cancer Center between January 1990 and June 2002. In all, 21 patients with nonleukemic GS, 1520 patients with acute myeloid leukemia (AML), and 402 patients with high-risk myelodysplastic syndrome (MDS) were identified. GS occurred in 1.4% of patients with AML, and 1.1% of patients with AML or high-risk MDSs. The median patient age was 57 years (range, 7-81). Among 20 patients with available cytogenetics in tissue and/or bone marrow, six had chromosome 8 abnormalities. The median follow-up of surviving patients is 12 months (range, 7-75). In all, 20 patients were treated. Patients were treated with AML-type chemotherapy (n=16), chemotherapy and radiotherapy (n=3), or radiotherapy alone (n=1). A total of 13 patients (65%) achieved complete remission and one patient (5%) achieved partial remission. The median overall survival was 20 months (range, 1-75), median overall failure-free survival was 12 months (range, 1-75). The median survival of patients with chromosome 8 abnormalities was 12 months compared with 40 months of those without (P=0.17). Novel therapies for patients with GS are required.
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols/adverse effects
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Child
- Chromosome Aberrations
- Chromosomes, Human, Pair 8/genetics
- Combined Modality Therapy
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Leukemia, Myeloid, Acute/genetics
- Leukemia, Myeloid, Acute/mortality
- Leukemia, Myeloid, Acute/therapy
- Male
- Middle Aged
- Myelodysplastic Syndromes/genetics
- Myelodysplastic Syndromes/mortality
- Myelodysplastic Syndromes/therapy
- Remission Induction
- Sarcoma, Myeloid/drug therapy
- Sarcoma, Myeloid/genetics
- Sarcoma, Myeloid/mortality
- Sarcoma, Myeloid/radiotherapy
- Survival Rate
- Treatment Outcome
Collapse
Affiliation(s)
- A-M Tsimberidou
- Department of Leukemia, The University of Texas, MD Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Asna N, Cohen Y, Ben-Yosef R. Primary radiation therapy for solitary chloroma of oral tongue. Isr Med Assoc J 2003; 5:452. [PMID: 12841024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Affiliation(s)
- Noam Asna
- Radiotherapy Unit, Division of Oncology, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel
| | | | | |
Collapse
|
12
|
El Khorassani M, Benbrahim F, Hessissen L, Khattab M, Msefer F. [Intracerebral granulocytic sarcoma. A case report]. Neurochirurgie 2003; 49:119-23. [PMID: 12746729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2023]
Abstract
Granulocytic sarcoma is a tumor composed of proliferating myeloblastic cells, generally found in the orbit. A brain localization is rare. We report the case of a 11-year-old boy treated in our unit for acute myeloblastic leukemia (AML 4 Eo. FAB). After 21 months of complete remission, he developed headache and facial palsy. The CT scan visualized the presence of two frontal and occipital masses. The spinal tap revealed blastic cells in the CSF. The study of the bone morrow showed medullar relapse. A new medullar and cerebro-meningeal remission was obtained with chemotherapy and radiotherapy. CSF and the bone marrow studies can help avoid stereotaxic biopsy can be avoided in this type of tumor
Collapse
Affiliation(s)
- M El Khorassani
- Unité d'Hématologie et d'Oncologie Pédiatrique, CHU Ibn Sina, Hôpital d'Enfants, Rabat, Maroc.
| | | | | | | | | |
Collapse
|
13
|
Affiliation(s)
- C Hon
- Department of Ophthalmology, Queen Mary Hospital, Hong Kong
| | | | | |
Collapse
|
14
|
Dimicoli S, Feugier P, Delaby P, Cannard L, Bland V, Witz F, Hulin C, Guerci A, Labouyrie E, Lederlin P. [Granulocyte sarcoma of the pancreas without extra-pancreatic location]. Presse Med 2002; 31:1024-6. [PMID: 12148256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/26/2023] Open
Abstract
INTRODUCTION Granulocyte sarcoma (GS), also known as chloroma, is a localized malignant tumor composed of myeloid cells, the diagnosis of which is difficult. The pancreatic location and recurrence, aside from any context of malignant hemopathy, are exceptional. OBSERVATION A 31-year-old woman developed an isolated and recurrent granulocyte sarcoma of the pancreas, without any context of a malignant hemopathy. The diagnosis retained on extemporaneous examination was an adenocarcinoma of the pancreas, because of the non-specific necrotic nature of the tumor. The immuno-histochemical exploration corrected the diagnosis. Despite local surgery, an isolated tumor recurred 6 months later. This relapse was treated with radiotherapy followed by heavy chemotherapy, identical to that applied in acute myeloblastic leukemia (AML). Ten months later, remission was stable and complete. COMMENTS Isolated granulocyte sarcomas located in the pancreas are exceptional and have often led to initial erroneous diagnosis. Immuno-histochemical methods are essential in order to obtain correct diagnosis. Despite the localized nature of the tumor, intensive AML-type chemotherapy is necessary.
Collapse
Affiliation(s)
- S Dimicoli
- Service d'Hématologie et de Médecine Interne, CHU Nancy-Brabois, Allée du Morvan, 54511 Vandoeuvre
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Brock WD, Brown HH, Westfall CT. Extramedullary myeloid cell tumor in an elderly man. Arch Ophthalmol 2001; 119:1861-4. [PMID: 11735806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Affiliation(s)
- W D Brock
- Harvey and Bernice Jones Eye Institute, Department of Ophthalmology, University of Arkansas for Medical Sciences, 4301 W Markham, Slot 523, Little Rock, AR 72205-7199, USA
| | | | | |
Collapse
|